As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps.
Three small cap shares that could be worth adding to your watchlist are listed below. Here’s what you need to know about them:
Adore Beauty Group Limited (ASX: ABY
The first small cap share to look at is Australia’s leading online beauty retailer, Adore Beauty. Although the company has come along way since being founded in a Melbourne garage in 1999, it still only has a modest slice of the Australian beauty and personal care market. This market is estimated to be worth $11.2 billion a year at present, which gives Adore Beauty a long runway for growth. Especially given the structural shift online and its growing customer base, which is approaching 1 million.
UBS remains positive on Adore Beauty. It recently retained its buy rating with a $4.70 price target.
Avita Medical Ltd (ASX: AVH
Another small cap ASX share to look at is Avita Medical. It is a global regenerative medicine company best known for its Recell system. This is a spray-on skin treatment used for burns victims. It is also looking to use its system to treat vitiligo and is working on an interesting project with Houston Methodist Research Institute. That project is essentially looking for the fountain of youth by finding a way to reverse cellular ageing.
Bell Potter is positive on the company. It has a speculative buy rating and $4.60 price target on its shares.
Mach7 Technologies Ltd (ASX: M7T
A final small cap ASX share to watch is Mach7. It is a medical imaging data management solutions provider that allows users to create a clear and complete view of the patient. Operators then use this to help them inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. It appears well-placed for the future, particularly given how demand for this type of software continues to grow thanks to industry tailwinds such as telehealth.
Morgans is a fan of the company. It currently has an add rating and $1.55 price target on the company’s shares.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
- 2 ASX growth shares analysts say have 40%+ upside
- Avita Medical (ASX:AVH) share price soars 23% as earnings stage a comeback
- Top ASX shares to buy in March 2022
- Analysts are tipping massive upside potential for these ASX growth shares
- Is now the time to buy these 2 beaten-up ASX shares in March 2022?
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Avita Medical Limited and MACH7 FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Adore Beauty Group Limited. The Motley Fool Australia has recommended Adore Beauty Group Limited, Avita Medical Limited, and MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/m1lDcvb